Nucleai
PrivateLast Round
Series B
Extension
Apr 3, 2024
Total Funding Raised
$58.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nucleai is a biotechnology company that offers a spatial biology software platform designed to enhance precision medicine through advanced artificial intelligence and machine learning technologies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Drug Discovery, Medical AI, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleai Comparables
Compare Nucleai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aignostics | 87% | |
| Panakeia | 84% | |
| Visiopharm | 82% | |
Nucleai Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Apr 3, 2024 | ||||
| Series B | Mar 22, 2022 | ||||
| Series A | Jul 7, 2020 | ||||
| Seed | Mar 5, 2018 |
Key People
Founding team and executive leadership
Nucleai Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B Extension, Series B |
| Fosun RZ Capital | Series B Extension, Series B |
| Grove Ventures | Series A, Series B Extension, Series B, Seed |
| M Ventures | Series B Extension |
| Vvc Advisors | Series B |
| Fosun International | Series B |
| Vertex Ventures Israel | Series A, Series B Extension, Series B, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Integrated spatial proteomics solution for drug development.
- Apr 15, 2026
Integrated spatial proteomics solution launched with Sirona Dx.
Nucleai Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucleai's valuation, stock price, and market status.